The Food and Drug Administration (FDA) has approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours. “This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years. With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical,” said FDA Commissioner Scott Gottlieb, MD.
FDA approves new flu treatment
245
Stay Connected
Unified Voice Newsletter
Events This Month
Event Type
All
Board & Council Meeting
Closed - Holiday
Community Events
Conference
Conferences
Cracker Barrells and Legislative Coffees
District Meeting
Education Events
Forum
Legislative Events
SDAHO Events
Webinar
Event Type 2
All
Hospice/Palliative Care
Long-Term Care
Event Location
All
Britton, SD
Brookings, SD
Canton, SD
Deadwood, SD
Freeman, SD
Holiday Inn & Suites - Airport
Huron, SD
Mitchell
Online
Pierre, SD
Rapid City, SD
Sioux Falls, SD
Sisseton
Spearfish, SD
december